In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)

Recently, human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ), encoded from a minus strand mRNA was discovered and was suggested to play an important role in adult T cell leukemia (ATL) development. However, there have been no reports on the role of HBZ in patients with HTL...

Full description

Saved in:
Bibliographic Details
Published inRetrovirology Vol. 6; no. 1; p. 19
Main Authors Saito, Mineki, Matsuzaki, Toshio, Satou, Yorifumi, Yasunaga, Jun-ichirou, Saito, Kousuke, Arimura, Kimiyoshi, Matsuoka, Masao, Ohara, Yoshiro
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 19.02.2009
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Recently, human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ), encoded from a minus strand mRNA was discovered and was suggested to play an important role in adult T cell leukemia (ATL) development. However, there have been no reports on the role of HBZ in patients with HTLV-1 associated inflammatory diseases. We quantified the HBZ and tax mRNA expression levels in peripheral blood from 56 HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, 10 ATL patients, 38 healthy asymptomatic carriers (HCs) and 20 normal uninfected controls, as well as human leukemic T-cell lines and HTLV-1-infected T-cell lines, and the data were correlated with clinical parameters. The spliced HBZ gene was transcribed in all HTLV-1-infected individuals examined, whereas tax mRNA was not transcribed in significant numbers of subjects in the same groups. Although the amount of HBZ mRNA expression was highest in ATL, medium in HAM/TSP, and lowest in HCs, with statistical significance, neither tax nor the HBZ mRNA expression per HTLV-1-infected cell differed significantly between each clinical group. The HTLV-1 HBZ, but not tax mRNA load, positively correlated with disease severity and with neopterin concentration in the cerebrospinal fluid of HAM/TSP patients. Furthermore, HBZ mRNA expression per HTLV-1-infected cell was decreased after successful immunomodulatory treatment for HAM/TSP. These findings suggest that in vivo expression of HBZ plays a role in HAM/TSP pathogenesis.
AbstractList BACKGROUND: Recently, human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ), encoded from a minus strand mRNA was discovered and was suggested to play an important role in adult T cell leukemia (ATL) development. However, there have been no reports on the role of HBZ in patients with HTLV-1 associated inflammatory diseases. RESULTS: We quantified the HBZ and tax mRNA expression levels in peripheral blood from 56 HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, 10 ATL patients, 38 healthy asymptomatic carriers (HCs) and 20 normal uninfected controls, as well as human leukemic T-cell lines and HTLV-1-infected T-cell lines, and the data were correlated with clinical parameters. The spliced HBZ gene was transcribed in all HTLV-1-infected individuals examined, whereas tax mRNA was not transcribed in significant numbers of subjects in the same groups. Although the amount of HBZ mRNA expression was highest in ATL, medium in HAM/TSP, and lowest in HCs, with statistical significance, neither tax nor the HBZ mRNA expression per HTLV-1-infected cell differed significantly between each clinical group. The HTLV-1 HBZ, but not tax mRNA load, positively correlated with disease severity and with neopterin concentration in the cerebrospinal fluid of HAM/TSP patients. Furthermore, HBZ mRNA expression per HTLV-1-infected cell was decreased after successful immunomodulatory treatment for HAM/TSP. CONCLUSION: These findings suggest that in vivo expression of HBZ plays a role in HAM/TSP pathogenesis.
Abstract Background Recently, human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ), encoded from a minus strand mRNA was discovered and was suggested to play an important role in adult T cell leukemia (ATL) development. However, there have been no reports on the role of HBZ in patients with HTLV-1 associated inflammatory diseases. Results We quantified the HBZ and tax mRNA expression levels in peripheral blood from 56 HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, 10 ATL patients, 38 healthy asymptomatic carriers (HCs) and 20 normal uninfected controls, as well as human leukemic T-cell lines and HTLV-1-infected T-cell lines, and the data were correlated with clinical parameters. The spliced HBZ gene was transcribed in all HTLV-1-infected individuals examined, whereas tax mRNA was not transcribed in significant numbers of subjects in the same groups. Although the amount of HBZ mRNA expression was highest in ATL, medium in HAM/TSP, and lowest in HCs, with statistical significance, neither tax nor the HBZ mRNA expression per HTLV-1-infected cell differed significantly between each clinical group. The HTLV-1 HBZ, but not tax mRNA load, positively correlated with disease severity and with neopterin concentration in the cerebrospinal fluid of HAM/TSP patients. Furthermore, HBZ mRNA expression per HTLV-1-infected cell was decreased after successful immunomodulatory treatment for HAM/TSP. Conclusion These findings suggest that in vivo expression of HBZ plays a role in HAM/TSP pathogenesis.
Recently, human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ), encoded from a minus strand mRNA was discovered and was suggested to play an important role in adult T cell leukemia (ATL) development. However, there have been no reports on the role of HBZ in patients with HTLV-1 associated inflammatory diseases.BACKGROUNDRecently, human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ), encoded from a minus strand mRNA was discovered and was suggested to play an important role in adult T cell leukemia (ATL) development. However, there have been no reports on the role of HBZ in patients with HTLV-1 associated inflammatory diseases.We quantified the HBZ and tax mRNA expression levels in peripheral blood from 56 HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, 10 ATL patients, 38 healthy asymptomatic carriers (HCs) and 20 normal uninfected controls, as well as human leukemic T-cell lines and HTLV-1-infected T-cell lines, and the data were correlated with clinical parameters. The spliced HBZ gene was transcribed in all HTLV-1-infected individuals examined, whereas tax mRNA was not transcribed in significant numbers of subjects in the same groups. Although the amount of HBZ mRNA expression was highest in ATL, medium in HAM/TSP, and lowest in HCs, with statistical significance, neither tax nor the HBZ mRNA expression per HTLV-1-infected cell differed significantly between each clinical group. The HTLV-1 HBZ, but not tax mRNA load, positively correlated with disease severity and with neopterin concentration in the cerebrospinal fluid of HAM/TSP patients. Furthermore, HBZ mRNA expression per HTLV-1-infected cell was decreased after successful immunomodulatory treatment for HAM/TSP.RESULTSWe quantified the HBZ and tax mRNA expression levels in peripheral blood from 56 HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, 10 ATL patients, 38 healthy asymptomatic carriers (HCs) and 20 normal uninfected controls, as well as human leukemic T-cell lines and HTLV-1-infected T-cell lines, and the data were correlated with clinical parameters. The spliced HBZ gene was transcribed in all HTLV-1-infected individuals examined, whereas tax mRNA was not transcribed in significant numbers of subjects in the same groups. Although the amount of HBZ mRNA expression was highest in ATL, medium in HAM/TSP, and lowest in HCs, with statistical significance, neither tax nor the HBZ mRNA expression per HTLV-1-infected cell differed significantly between each clinical group. The HTLV-1 HBZ, but not tax mRNA load, positively correlated with disease severity and with neopterin concentration in the cerebrospinal fluid of HAM/TSP patients. Furthermore, HBZ mRNA expression per HTLV-1-infected cell was decreased after successful immunomodulatory treatment for HAM/TSP.These findings suggest that in vivo expression of HBZ plays a role in HAM/TSP pathogenesis.CONCLUSIONThese findings suggest that in vivo expression of HBZ plays a role in HAM/TSP pathogenesis.
Recently, human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ), encoded from a minus strand mRNA was discovered and was suggested to play an important role in adult T cell leukemia (ATL) development. However, there have been no reports on the role of HBZ in patients with HTLV-1 associated inflammatory diseases. We quantified the HBZ and tax mRNA expression levels in peripheral blood from 56 HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, 10 ATL patients, 38 healthy asymptomatic carriers (HCs) and 20 normal uninfected controls, as well as human leukemic T-cell lines and HTLV-1-infected T-cell lines, and the data were correlated with clinical parameters. The spliced HBZ gene was transcribed in all HTLV-1-infected individuals examined, whereas tax mRNA was not transcribed in significant numbers of subjects in the same groups. Although the amount of HBZ mRNA expression was highest in ATL, medium in HAM/TSP, and lowest in HCs, with statistical significance, neither tax nor the HBZ mRNA expression per HTLV-1-infected cell differed significantly between each clinical group. The HTLV-1 HBZ, but not tax mRNA load, positively correlated with disease severity and with neopterin concentration in the cerebrospinal fluid of HAM/TSP patients. Furthermore, HBZ mRNA expression per HTLV-1-infected cell was decreased after successful immunomodulatory treatment for HAM/TSP. These findings suggest that in vivo expression of HBZ plays a role in HAM/TSP pathogenesis.
ArticleNumber 19
Audience Academic
Author Matsuoka, Masao
Saito, Kousuke
Matsuzaki, Toshio
Ohara, Yoshiro
Satou, Yorifumi
Arimura, Kimiyoshi
Saito, Mineki
Yasunaga, Jun-ichirou
AuthorAffiliation 4 Department of Immunology, Graduate School of Medicine, University of the Ryukyus, Okinawa 903-0215, Japan
2 Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima 890-8520, Japan
1 Department of Microbiology, Kanazawa Medical University, Ishikawa 920-0293, Japan
3 Laboratory of Virus Immunology, Institute for Virus Research, Kyoto University, Kyoto 606-8507, Japan
AuthorAffiliation_xml – name: 4 Department of Immunology, Graduate School of Medicine, University of the Ryukyus, Okinawa 903-0215, Japan
– name: 3 Laboratory of Virus Immunology, Institute for Virus Research, Kyoto University, Kyoto 606-8507, Japan
– name: 2 Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima 890-8520, Japan
– name: 1 Department of Microbiology, Kanazawa Medical University, Ishikawa 920-0293, Japan
Author_xml – sequence: 1
  givenname: Mineki
  surname: Saito
  fullname: Saito, Mineki
– sequence: 2
  givenname: Toshio
  surname: Matsuzaki
  fullname: Matsuzaki, Toshio
– sequence: 3
  givenname: Yorifumi
  surname: Satou
  fullname: Satou, Yorifumi
– sequence: 4
  givenname: Jun-ichirou
  surname: Yasunaga
  fullname: Yasunaga, Jun-ichirou
– sequence: 5
  givenname: Kousuke
  surname: Saito
  fullname: Saito, Kousuke
– sequence: 6
  givenname: Kimiyoshi
  surname: Arimura
  fullname: Arimura, Kimiyoshi
– sequence: 7
  givenname: Masao
  surname: Matsuoka
  fullname: Matsuoka, Masao
– sequence: 8
  givenname: Yoshiro
  surname: Ohara
  fullname: Ohara, Yoshiro
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19228429$$D View this record in MEDLINE/PubMed
BookMark eNp1kl2L1DAUhousuB9666UEBFGws0natM2NMC7qDKwoOHrhTUiT05msbVOTzOj8N3-cqbM77OhKCGnPec_DOcl7mhz1tockeUzwhJCqOCdlTtO84DgtUsLvJSf7wNGt7-Pk1PsrjDNS4epBckw4pVVO-Unya96jjdlYBD8HB94b2yPboLACNHv9FS2hh_F_trj8khKkrHPQygAe_TBhhQZnN8bJFrVW6pfI9E0ru04G67aok-4bOI9kr5E2HqQH5GEDzoRtVN4gpfdWmYjUqNtCawcZVtvz4OxgVAT7QfpgFBqkk3GDNx49n03fny8-fXzxMLnfyNbDo-vzLPn89s3iYpZefng3v5hepjUreUihorouOeXAFCmI1JTSWuckp6TMqprFfKNyignlZV0QqBiVtNAyzwnJVMays2S-42orr8TgTJxtK6w04k_AuqWQLnbZgmhUrXGjMNOc5aUGyRUpma4rxkrJMh5Zr3asYV13oBX0IV7gAfQw05uVWNqNoAXL8gJHwHQHqI39D-Awo2wnRieI0QmiEGRs4tl1E85-X4MPojNeQdvKHuzai6LEuOJx-rPk6U64lHG4-L42ItUoFlPCGckx5yNucocqLg2dUdGwjYnxg4Inty9h3_yNL6Mg3wmUs947aIQyQYbozkg2rSBYjPb_d67JX2V78t0FvwEQ3weN
CitedBy_id crossref_primary_10_1158_0008_5472_CAN_15_0942
crossref_primary_10_3389_fmicb_2018_00558
crossref_primary_10_1111_trf_12911
crossref_primary_10_1016_j_leukres_2024_107454
crossref_primary_10_1155_2012_391953
crossref_primary_10_1186_1742_4690_8_102
crossref_primary_10_12688_wellcomeopenres_12469_2
crossref_primary_10_3389_fmicb_2019_00885
crossref_primary_10_12688_wellcomeopenres_12469_1
crossref_primary_10_1007_s11033_023_08626_8
crossref_primary_10_3389_fmicb_2020_614940
crossref_primary_10_3389_fmicb_2022_897346
crossref_primary_10_3389_fmed_2022_867478
crossref_primary_10_1371_journal_ppat_1001117
crossref_primary_10_3390_v7072793
crossref_primary_10_1186_1742_4690_9_46
crossref_primary_10_1186_1742_2094_11_18
crossref_primary_10_3389_fmicb_2018_00285
crossref_primary_10_1128_JVI_00413_19
crossref_primary_10_2222_jsv_62_113
crossref_primary_10_3390_ijms23105486
crossref_primary_10_2217_fmb_09_13
crossref_primary_10_1093_carcin_bgt221
crossref_primary_10_1159_000371766
crossref_primary_10_1038_onc_2010_537
crossref_primary_10_1111_j_1365_2133_2010_09681_x
crossref_primary_10_1007_s13365_020_00881_w
crossref_primary_10_1051_medsci_2010264391
crossref_primary_10_1128_JVI_02088_09
crossref_primary_10_1371_journal_ppat_1004575
crossref_primary_10_1586_eri_09_97
crossref_primary_10_1016_j_virol_2016_04_012
crossref_primary_10_1586_1744666X_2014_966690
crossref_primary_10_1371_journal_ppat_1006597
crossref_primary_10_1155_2012_213653
crossref_primary_10_1186_s12977_016_0249_x
crossref_primary_10_1590_S0037_86822012000500002
crossref_primary_10_1186_s12985_017_0902_6
crossref_primary_10_1186_s12985_019_1270_1
crossref_primary_10_1371_journal_pntd_0008361
crossref_primary_10_2169_internalmedicine_52_0845
crossref_primary_10_1371_journal_pntd_0001729
crossref_primary_10_1371_journal_ppat_1009219
crossref_primary_10_1080_10408363_2022_2157791
crossref_primary_10_3389_fimmu_2022_991928
crossref_primary_10_1186_1742_4690_6_71
crossref_primary_10_1186_s12977_019_0484_z
crossref_primary_10_1186_1742_4690_6_76
crossref_primary_10_1186_1742_4690_6_77
crossref_primary_10_1186_s12977_019_0487_9
crossref_primary_10_1371_journal_ppat_1002025
crossref_primary_10_1371_journal_ppat_1003630
crossref_primary_10_1016_S1473_3099_20_30328_5
crossref_primary_10_3389_fmicb_2017_02615
crossref_primary_10_1371_journal_pntd_0002028
crossref_primary_10_3390_v11110974
crossref_primary_10_1007_s00428_025_04074_w
crossref_primary_10_1111_cen3_12395
crossref_primary_10_1158_2326_6066_CIR_15_0148
crossref_primary_10_3390_mi12020159
crossref_primary_10_1186_1743_422X_11_172
crossref_primary_10_1002_jmv_24721
crossref_primary_10_1186_s12977_014_0116_6
crossref_primary_10_3389_fcimb_2020_580371
crossref_primary_10_1155_2012_259045
crossref_primary_10_1186_1742_4690_10_19
crossref_primary_10_1007_s11538_011_9657_1
crossref_primary_10_1186_s12977_018_0454_x
crossref_primary_10_1186_s12977_016_0263_z
crossref_primary_10_1002_rmv_1745
crossref_primary_10_3389_fimmu_2022_984274
crossref_primary_10_1093_infdis_jir708
crossref_primary_10_3390_v2092037
crossref_primary_10_1007_s00430_019_00625_6
crossref_primary_10_3389_fmicb_2017_02563
crossref_primary_10_3389_fmicb_2017_02684
crossref_primary_10_1128_CMR_00063_09
crossref_primary_10_1128_JVI_00853_17
crossref_primary_10_1016_j_neurol_2011_12_006
crossref_primary_10_1158_0008_5472_CAN_13_3564
crossref_primary_10_1016_j_virusres_2016_11_009
crossref_primary_10_1002_jmv_24342
crossref_primary_10_1016_S0929_6646_10_60112_X
crossref_primary_10_1016_j_bjid_2021_101594
crossref_primary_10_3390_jcm6120111
crossref_primary_10_1182_blood_2010_11_321364
crossref_primary_10_1371_journal_ppat_1001274
crossref_primary_10_1038_onc_2012_450
crossref_primary_10_1371_journal_ppat_1002480
crossref_primary_10_1016_j_coviro_2013_08_010
crossref_primary_10_1177_0300985810370009
crossref_primary_10_3389_fmicb_2018_00985
crossref_primary_10_3389_fviro_2021_792659
crossref_primary_10_1002_acn3_51437
crossref_primary_10_1007_s13365_015_0407_2
crossref_primary_10_2177_jsci_39_207
crossref_primary_10_1002_jmv_29912
crossref_primary_10_1128_JVI_00661_12
crossref_primary_10_1186_1742_4690_8_19
crossref_primary_10_1128_JVI_01094_14
crossref_primary_10_1128_spectrum_01518_23
crossref_primary_10_1186_s12977_019_0499_5
crossref_primary_10_1093_infdis_jiq078
crossref_primary_10_1016_j_mam_2010_06_002
crossref_primary_10_1186_s12985_017_0802_9
crossref_primary_10_1371_journal_ppat_1002231
crossref_primary_10_3390_v3060714
crossref_primary_10_1016_j_ijid_2024_107058
crossref_primary_10_3390_v8020034
crossref_primary_10_1007_s13365_020_00832_5
crossref_primary_10_3390_v3050456
crossref_primary_10_1016_j_pharmthera_2020_107669
crossref_primary_10_1186_s12985_023_02264_z
crossref_primary_10_1371_journal_pntd_0005285
crossref_primary_10_1158_0008_5472_CAN_16_0361
crossref_primary_10_1016_j_revmed_2014_11_013
crossref_primary_10_1038_s41408_023_00841_7
crossref_primary_10_3389_fmicb_2022_988944
crossref_primary_10_1186_1742_4690_9_98
crossref_primary_10_1186_s12977_014_0074_z
crossref_primary_10_1590_S0100_879X2010007500107
crossref_primary_10_1186_s12885_018_5209_5
crossref_primary_10_2222_jsv_69_37
crossref_primary_10_3390_v16101616
crossref_primary_10_1016_j_jcv_2012_10_003
crossref_primary_10_3390_v3091532
crossref_primary_10_1186_1742_4690_10_51
crossref_primary_10_1182_blood_2010_05_284141
crossref_primary_10_3389_fmicb_2020_01062
crossref_primary_10_4161_viru_1_1_9868
Cites_doi 10.1016/S0140-6736(85)92734-5
10.1074/jbc.M307275200
10.1002/ijc.24012
10.1099/vir.0.80509-0
10.1128/JVI.00480-06
10.1016/0167-5699(88)91203-0
10.1097/00005072-199401000-00009
10.1002/(SICI)1097-0215(20000201)85:3<319::AID-IJC4>3.0.CO;2-B
10.1126/science.2888190
10.1073/pnas.96.7.3848
10.1182/blood-2005-11-4551
10.1073/pnas.0507631103
10.1038/nm1389
10.1073/pnas.77.12.7415
10.1086/315897
10.1111/j.1365-2257.2005.00698.x
10.3109/13550289609146899
10.1111/j.1349-7006.1992.tb00092.x
10.1128/JVI.63.7.3185-3189.1989
10.1146/annurev.immunol.19.1.475
10.1007/s004010050435
10.1038/sj.onc.1208970
10.1126/science.2888191
10.1182/blood.V85.7.1865.bloodjournal8571865
10.1186/1742-4690-5-34
10.4049/jimmunol.165.12.7278
10.1002/mus.880160507
10.1212/WNL.33.11.1444
10.1006/viro.1993.1580
10.1212/WNL.41.3.457
10.1097/00005072-199809000-00005
10.1016/S0140-6736(87)91362-6
10.1182/blood.V99.1.88
10.1038/341072a0
10.1002/(SICI)1096-9896(1998100)186:2<209::AID-PATH162>3.0.CO;2-I
10.1128/JVI.76.24.12813-12822.2002
10.1016/S0140-6736(86)91298-5
10.1186/1742-4690-2-27
10.1182/blood-2005-04-1730
10.3109/13550289809114225
10.1126/science.1887217
10.1212/WNL.46.4.1016
10.1073/pnas.92.4.1057
10.1038/nm0507-527
10.1016/S0140-6736(89)90038-X
10.1128/JVI.80.5.2495-2505.2006
10.1086/380101
10.1073/pnas.79.6.2031
10.1128/JVI.77.5.2956-2963.2003
10.1097/00126334-200303010-00013
10.1073/pnas.81.8.2534
10.1186/1742-4690-3-15
10.1073/pnas.78.10.6476
ContentType Journal Article
Copyright COPYRIGHT 2009 BioMed Central Ltd.
Copyright © 2009 Saito et al; licensee BioMed Central Ltd. 2009 Saito et al; licensee BioMed Central Ltd.
Copyright_xml – notice: COPYRIGHT 2009 BioMed Central Ltd.
– notice: Copyright © 2009 Saito et al; licensee BioMed Central Ltd. 2009 Saito et al; licensee BioMed Central Ltd.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1186/1742-4690-6-19
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1742-4690
EndPage 19
ExternalDocumentID oai_doaj_org_article_fcbd0fc05d9547dea9c175db8557a539
PMC2653460
oai_biomedcentral_com_1742_4690_6_19
A195140999
19228429
10_1186_1742_4690_6_19
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID ---
0R~
123
29P
2WC
4.4
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SOJ
SV3
TR2
TUS
UKHRP
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PMFND
7X8
-A0
3V.
ABVAZ
ACRMQ
ADINQ
AFGXO
AFNRJ
C24
5PM
PUEGO
ID FETCH-LOGICAL-b579t-e82db7929e5c161ad222bd41421738b5e82fc4201297b61e852a26da44113c353
IEDL.DBID RBZ
ISSN 1742-4690
IngestDate Wed Aug 27 01:22:30 EDT 2025
Thu Aug 21 18:45:51 EDT 2025
Wed May 22 07:12:46 EDT 2024
Mon Jul 21 10:04:18 EDT 2025
Tue Jun 17 22:19:20 EDT 2025
Tue Jun 10 21:15:30 EDT 2025
Mon Jul 21 06:03:41 EDT 2025
Tue Jul 01 03:39:28 EDT 2025
Thu Apr 24 23:09:03 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License http://creativecommons.org/licenses/by/2.0
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b579t-e82db7929e5c161ad222bd41421738b5e82fc4201297b61e852a26da44113c353
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://dx.doi.org/10.1186/1742-4690-6-19
PMID 19228429
PQID 67008911
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_fcbd0fc05d9547dea9c175db8557a539
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2653460
biomedcentral_primary_oai_biomedcentral_com_1742_4690_6_19
proquest_miscellaneous_67008911
gale_infotracmisc_A195140999
gale_infotracacademiconefile_A195140999
pubmed_primary_19228429
crossref_citationtrail_10_1186_1742_4690_6_19
crossref_primary_10_1186_1742_4690_6_19
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-02-19
PublicationDateYYYYMMDD 2009-02-19
PublicationDate_xml – month: 02
  year: 2009
  text: 2009-02-19
  day: 19
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Retrovirology
PublicationTitleAlternate Retrovirology
PublicationYear 2009
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References F Umehara (1024_CR16) 1998; 57
BJ Poiesz (1024_CR1) 1980; 77
BM Birmann (1024_CR55) 2008; 1:124
A Hasegawa (1024_CR46) 2003; 77
Y Shimizu (1024_CR47) 2008
M Yoshida (1024_CR13) 2001; 19
L Gao (1024_CR26) 2005; 106
JE Green (1024_CR22) 1989; 341
S Kamihira (1024_CR45) 2005; 27
J Arnold (1024_CR34) 2006; 107
M Nomoto (1024_CR40) 1991; 41
F Umehara (1024_CR14) 1994; 53
S Izumo (1024_CR41) 1996; 46
MH Cavanagh (1024_CR39) 2006; 3
Y Yamano (1024_CR17) 2002; 99
AH Sabouri (1024_CR53) 2005; 86
Y Satou (1024_CR32) 2006; 103
K Arisawa (1024_CR7) 2000; 85
AP Hall (1024_CR25) 1998; 186
M Sugimoto (1024_CR9) 1987; 2
NH Ruddle (1024_CR24) 1993; 197
I Higuchi (1024_CR11) 1993; 16
M Osame (1024_CR35) 1990
T Matsuzaki (1024_CR43) 2005; 15:237
CR Bangham (1024_CR12) 2005; 24
M Nagai (1024_CR36) 1998; 4
K Murata (1024_CR38) 2006; 80
M Nerenberg (1024_CR21) 1987; 237
M Matsuoka (1024_CR19) 2005; 2
SH Hinrichs (1024_CR20) 1987; 237
M Yoshida (1024_CR2) 1982; 79
Y Furuta (1024_CR27) 1989; 63
WJ Grossman (1024_CR28) 1995; 92
M Yoshida (1024_CR4) 1984; 81
Y Iwakura (1024_CR23) 1991; 253
JF Kurtzke (1024_CR44) 1983; 33
T Ohsugi (1024_CR30) 2007; 13
G Gaudray (1024_CR31) 2002; 76
KJ Jeffery (1024_CR52) 2000; 165
Y Hinuma (1024_CR3) 1981; 78
M Saito (1024_CR42) 2004; 189
F Umehara (1024_CR15) 1996; 91
H Hasegawa (1024_CR29) 2006; 12
K Nishioka (1024_CR10) 1989; 1
M Mochizuki (1024_CR8) 1992; 83
T Usui (1024_CR37) 2008; 5
A Gessain (1024_CR5) 1985; 2
D Fuchs (1024_CR49) 1988; 9
Y Furukawa (1024_CR18) 1995; 85
Y Furukawa (1024_CR50) 2003; 32
J Basbous (1024_CR33) 2003; 278
Y Furukawa (1024_CR54) 2000; 182
KJ Jeffery (1024_CR51) 1999; 96
M Osame (1024_CR6) 1986; 1
M Nakagawa (1024_CR56) 1996; 2
I Lemasson (1024_CR48) 2007; 81
8212554 - Virology. 1993 Nov;197(1):196-204
16155610 - Oncogene. 2005 Sep 5;24(39):6035-46
15854229 - Retrovirology. 2005;2:27
19154412 - Cancer Sci. 2009 Mar;100(3):481-9
2888190 - Science. 1987 Sep 11;237(4820):1324-9
17479090 - Nat Med. 2007 May;13(5):527-8
16407133 - Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):720-5
11756157 - Blood. 2002 Jan 1;99(1):88-94
12626894 - J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):328-34
10065900 - J Neurovirol. 1998 Dec;4(6):586-93
16550188 - Nat Med. 2006 Apr;12(4):466-72
16512901 - Retrovirology. 2006;3:15
8515755 - Muscle Nerve. 1993 May;16(5):472-6
9737547 - J Neuropathol Exp Neurol. 1998 Sep;57(9):839-49
12584320 - J Virol. 2003 Mar;77(5):2956-63
8780082 - Neurology. 1996 Apr;46(4):1016-21
2888191 - Science. 1987 Sep 11;237(4820):1340-3
16424388 - Blood. 2006 May 15;107(10):3976-82
2890850 - Lancet. 1987 Nov 21;2(8569):1220
12438606 - J Virol. 2002 Dec;76(24):12813-22
11010842 - J Infect Dis. 2000 Nov;182(5):1343-9
1582883 - Jpn J Cancer Res. 1992 Mar;83(3):236-9
8912211 - J Neurovirol. 1996 Oct;2(5):345-55
15722539 - J Gen Virol. 2005 Mar;86(Pt 3):773-81
12937177 - J Biol Chem. 2003 Oct 31;278(44):43620-7
6326131 - Proc Natl Acad Sci U S A. 1984 Apr;81(8):2534-7
16118323 - Blood. 2005 Dec 15;106(13):4294-302
1887217 - Science. 1991 Aug 30;253(5023):1026-8
18989900 - Int J Cancer. 2009 Feb 1;124(3):614-21
11120862 - J Immunol. 2000 Dec 15;165(12):7278-84
16474156 - J Virol. 2006 Mar;80(5):2495-505
11244044 - Annu Rev Immunol. 2001;19:475-96
3076770 - Immunol Today. 1988 May;9(5):150-5
8301322 - J Neuropathol Exp Neurol. 1994 Jan;53(1):72-7
8928610 - Acta Neuropathol. 1996;91(4):343-50
6979048 - Proc Natl Acad Sci U S A. 1982 Mar;79(6):2031-5
7862633 - Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1057-61
17151132 - J Virol. 2007 Feb;81(4):1543-53
2563817 - Lancet. 1989 Feb 25;1(8635):441
15961107 - J Neurol Sci. 2005 Oct 15;237(1-2):75-81
10652420 - Int J Cancer. 2000 Feb 1;85(3):319-24
2863442 - Lancet. 1985 Aug 24;2(8452):407-10
2006023 - Neurology. 1991 Mar;41(3):457
9924438 - J Pathol. 1998 Oct;186(2):209-14
7703492 - Blood. 1995 Apr 1;85(7):1865-70
10097126 - Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3848-53
18426605 - Retrovirology. 2008;5:34
6261256 - Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9
6685237 - Neurology. 1983 Nov;33(11):1444-52
16048490 - Clin Lab Haematol. 2005 Aug;27(4):235-41
2871307 - Lancet. 1986 May 3;1(8488):1031-2
7031654 - Proc Natl Acad Sci U S A. 1981 Oct;78(10):6476-80
2724422 - J Virol. 1989 Jul;63(7):3185-9
14702150 - J Infect Dis. 2004 Jan 1;189(1):29-40
2788824 - Nature. 1989 Sep 7;341(6237):72-4
References_xml – volume: 2
  start-page: 407
  year: 1985
  ident: 1024_CR5
  publication-title: Lancet
  doi: 10.1016/S0140-6736(85)92734-5
– volume: 278
  start-page: 43620
  year: 2003
  ident: 1024_CR33
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M307275200
– volume: 1:124
  start-page: 614
  issue: 3
  year: 2008
  ident: 1024_CR55
  publication-title: Int J Cancer
  doi: 10.1002/ijc.24012
– volume: 86
  start-page: 773
  year: 2005
  ident: 1024_CR53
  publication-title: J Gen Virol
  doi: 10.1099/vir.0.80509-0
– volume: 81
  start-page: 1543
  year: 2007
  ident: 1024_CR48
  publication-title: J Virol
  doi: 10.1128/JVI.00480-06
– volume-title: Cancer Sci
  year: 2008
  ident: 1024_CR47
– volume: 9
  start-page: 150
  year: 1988
  ident: 1024_CR49
  publication-title: Immunol Today
  doi: 10.1016/0167-5699(88)91203-0
– volume: 53
  start-page: 72
  year: 1994
  ident: 1024_CR14
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1097/00005072-199401000-00009
– volume: 85
  start-page: 319
  year: 2000
  ident: 1024_CR7
  publication-title: Int J Cancer
  doi: 10.1002/(SICI)1097-0215(20000201)85:3<319::AID-IJC4>3.0.CO;2-B
– volume: 237
  start-page: 1324
  year: 1987
  ident: 1024_CR21
  publication-title: Science
  doi: 10.1126/science.2888190
– volume: 96
  start-page: 3848
  year: 1999
  ident: 1024_CR51
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.96.7.3848
– volume: 107
  start-page: 3976
  year: 2006
  ident: 1024_CR34
  publication-title: Blood
  doi: 10.1182/blood-2005-11-4551
– volume: 103
  start-page: 720
  year: 2006
  ident: 1024_CR32
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0507631103
– volume: 12
  start-page: 466
  year: 2006
  ident: 1024_CR29
  publication-title: Nat Med
  doi: 10.1038/nm1389
– volume: 77
  start-page: 7415
  year: 1980
  ident: 1024_CR1
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.77.12.7415
– volume: 182
  start-page: 1343
  year: 2000
  ident: 1024_CR54
  publication-title: J Infect Dis
  doi: 10.1086/315897
– volume: 27
  start-page: 235
  year: 2005
  ident: 1024_CR45
  publication-title: Clin Lab Haematol
  doi: 10.1111/j.1365-2257.2005.00698.x
– volume-title: Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP
  year: 1990
  ident: 1024_CR35
– volume: 2
  start-page: 345
  year: 1996
  ident: 1024_CR56
  publication-title: J Neurovirol
  doi: 10.3109/13550289609146899
– volume: 83
  start-page: 236
  year: 1992
  ident: 1024_CR8
  publication-title: Jpn J Cancer Res
  doi: 10.1111/j.1349-7006.1992.tb00092.x
– volume: 63
  start-page: 3185
  year: 1989
  ident: 1024_CR27
  publication-title: J Virol
  doi: 10.1128/JVI.63.7.3185-3189.1989
– volume: 19
  start-page: 475
  year: 2001
  ident: 1024_CR13
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.19.1.475
– volume: 91
  start-page: 343
  year: 1996
  ident: 1024_CR15
  publication-title: Acta Neuropathol (Berl)
  doi: 10.1007/s004010050435
– volume: 24
  start-page: 6035
  year: 2005
  ident: 1024_CR12
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1208970
– volume: 237
  start-page: 1340
  year: 1987
  ident: 1024_CR20
  publication-title: Science
  doi: 10.1126/science.2888191
– volume: 85
  start-page: 1865
  year: 1995
  ident: 1024_CR18
  publication-title: Blood
  doi: 10.1182/blood.V85.7.1865.bloodjournal8571865
– volume: 5
  start-page: 34
  year: 2008
  ident: 1024_CR37
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-5-34
– volume: 165
  start-page: 7278
  year: 2000
  ident: 1024_CR52
  publication-title: J Immunol
  doi: 10.4049/jimmunol.165.12.7278
– volume: 16
  start-page: 472
  year: 1993
  ident: 1024_CR11
  publication-title: Muscle Nerve
  doi: 10.1002/mus.880160507
– volume: 33
  start-page: 1444
  year: 1983
  ident: 1024_CR44
  publication-title: Neurology
  doi: 10.1212/WNL.33.11.1444
– volume: 197
  start-page: 196
  year: 1993
  ident: 1024_CR24
  publication-title: Virology
  doi: 10.1006/viro.1993.1580
– volume: 41
  start-page: 457
  year: 1991
  ident: 1024_CR40
  publication-title: Neurology
  doi: 10.1212/WNL.41.3.457
– volume: 57
  start-page: 839
  year: 1998
  ident: 1024_CR16
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1097/00005072-199809000-00005
– volume: 2
  start-page: 1220
  year: 1987
  ident: 1024_CR9
  publication-title: Lancet
  doi: 10.1016/S0140-6736(87)91362-6
– volume: 99
  start-page: 88
  year: 2002
  ident: 1024_CR17
  publication-title: Blood
  doi: 10.1182/blood.V99.1.88
– volume: 341
  start-page: 72
  year: 1989
  ident: 1024_CR22
  publication-title: Nature
  doi: 10.1038/341072a0
– volume: 15:237
  start-page: 1
  issue: 1–2
  year: 2005
  ident: 1024_CR43
  publication-title: J Neurol Sci
– volume: 186
  start-page: 209
  year: 1998
  ident: 1024_CR25
  publication-title: J Pathol
  doi: 10.1002/(SICI)1096-9896(1998100)186:2<209::AID-PATH162>3.0.CO;2-I
– volume: 76
  start-page: 12813
  year: 2002
  ident: 1024_CR31
  publication-title: J Virol
  doi: 10.1128/JVI.76.24.12813-12822.2002
– volume: 1
  start-page: 1031
  year: 1986
  ident: 1024_CR6
  publication-title: Lancet
  doi: 10.1016/S0140-6736(86)91298-5
– volume: 2
  start-page: 27
  year: 2005
  ident: 1024_CR19
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-2-27
– volume: 106
  start-page: 4294
  year: 2005
  ident: 1024_CR26
  publication-title: Blood
  doi: 10.1182/blood-2005-04-1730
– volume: 4
  start-page: 586
  year: 1998
  ident: 1024_CR36
  publication-title: J Neurovirol
  doi: 10.3109/13550289809114225
– volume: 253
  start-page: 1026
  year: 1991
  ident: 1024_CR23
  publication-title: Science
  doi: 10.1126/science.1887217
– volume: 46
  start-page: 1016
  year: 1996
  ident: 1024_CR41
  publication-title: Neurology
  doi: 10.1212/WNL.46.4.1016
– volume: 92
  start-page: 1057
  year: 1995
  ident: 1024_CR28
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.92.4.1057
– volume: 13
  start-page: 527
  year: 2007
  ident: 1024_CR30
  publication-title: Nat Med
  doi: 10.1038/nm0507-527
– volume: 1
  start-page: 441
  year: 1989
  ident: 1024_CR10
  publication-title: Lancet
  doi: 10.1016/S0140-6736(89)90038-X
– volume: 80
  start-page: 2495
  year: 2006
  ident: 1024_CR38
  publication-title: J Virol
  doi: 10.1128/JVI.80.5.2495-2505.2006
– volume: 189
  start-page: 29
  year: 2004
  ident: 1024_CR42
  publication-title: J Infect Dis
  doi: 10.1086/380101
– volume: 79
  start-page: 2031
  year: 1982
  ident: 1024_CR2
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.79.6.2031
– volume: 77
  start-page: 2956
  year: 2003
  ident: 1024_CR46
  publication-title: J Virol
  doi: 10.1128/JVI.77.5.2956-2963.2003
– volume: 32
  start-page: 328
  year: 2003
  ident: 1024_CR50
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/00126334-200303010-00013
– volume: 81
  start-page: 2534
  year: 1984
  ident: 1024_CR4
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.81.8.2534
– volume: 3
  start-page: 15
  year: 2006
  ident: 1024_CR39
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-3-15
– volume: 78
  start-page: 6476
  year: 1981
  ident: 1024_CR3
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.78.10.6476
– reference: 2871307 - Lancet. 1986 May 3;1(8488):1031-2
– reference: 2006023 - Neurology. 1991 Mar;41(3):457
– reference: 16118323 - Blood. 2005 Dec 15;106(13):4294-302
– reference: 12937177 - J Biol Chem. 2003 Oct 31;278(44):43620-7
– reference: 8912211 - J Neurovirol. 1996 Oct;2(5):345-55
– reference: 6979048 - Proc Natl Acad Sci U S A. 1982 Mar;79(6):2031-5
– reference: 10652420 - Int J Cancer. 2000 Feb 1;85(3):319-24
– reference: 8301322 - J Neuropathol Exp Neurol. 1994 Jan;53(1):72-7
– reference: 17479090 - Nat Med. 2007 May;13(5):527-8
– reference: 6326131 - Proc Natl Acad Sci U S A. 1984 Apr;81(8):2534-7
– reference: 2888191 - Science. 1987 Sep 11;237(4820):1340-3
– reference: 12626894 - J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):328-34
– reference: 16155610 - Oncogene. 2005 Sep 5;24(39):6035-46
– reference: 17151132 - J Virol. 2007 Feb;81(4):1543-53
– reference: 15854229 - Retrovirology. 2005;2:27
– reference: 2863442 - Lancet. 1985 Aug 24;2(8452):407-10
– reference: 6261256 - Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9
– reference: 15722539 - J Gen Virol. 2005 Mar;86(Pt 3):773-81
– reference: 16550188 - Nat Med. 2006 Apr;12(4):466-72
– reference: 11120862 - J Immunol. 2000 Dec 15;165(12):7278-84
– reference: 18426605 - Retrovirology. 2008;5:34
– reference: 3076770 - Immunol Today. 1988 May;9(5):150-5
– reference: 8212554 - Virology. 1993 Nov;197(1):196-204
– reference: 14702150 - J Infect Dis. 2004 Jan 1;189(1):29-40
– reference: 10097126 - Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3848-53
– reference: 2563817 - Lancet. 1989 Feb 25;1(8635):441
– reference: 19154412 - Cancer Sci. 2009 Mar;100(3):481-9
– reference: 7703492 - Blood. 1995 Apr 1;85(7):1865-70
– reference: 1582883 - Jpn J Cancer Res. 1992 Mar;83(3):236-9
– reference: 1887217 - Science. 1991 Aug 30;253(5023):1026-8
– reference: 16407133 - Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):720-5
– reference: 2888190 - Science. 1987 Sep 11;237(4820):1324-9
– reference: 7862633 - Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1057-61
– reference: 18989900 - Int J Cancer. 2009 Feb 1;124(3):614-21
– reference: 2724422 - J Virol. 1989 Jul;63(7):3185-9
– reference: 16474156 - J Virol. 2006 Mar;80(5):2495-505
– reference: 16424388 - Blood. 2006 May 15;107(10):3976-82
– reference: 6685237 - Neurology. 1983 Nov;33(11):1444-52
– reference: 2788824 - Nature. 1989 Sep 7;341(6237):72-4
– reference: 9737547 - J Neuropathol Exp Neurol. 1998 Sep;57(9):839-49
– reference: 7031654 - Proc Natl Acad Sci U S A. 1981 Oct;78(10):6476-80
– reference: 8515755 - Muscle Nerve. 1993 May;16(5):472-6
– reference: 12584320 - J Virol. 2003 Mar;77(5):2956-63
– reference: 9924438 - J Pathol. 1998 Oct;186(2):209-14
– reference: 10065900 - J Neurovirol. 1998 Dec;4(6):586-93
– reference: 2890850 - Lancet. 1987 Nov 21;2(8569):1220
– reference: 11244044 - Annu Rev Immunol. 2001;19:475-96
– reference: 15961107 - J Neurol Sci. 2005 Oct 15;237(1-2):75-81
– reference: 16048490 - Clin Lab Haematol. 2005 Aug;27(4):235-41
– reference: 8780082 - Neurology. 1996 Apr;46(4):1016-21
– reference: 16512901 - Retrovirology. 2006;3:15
– reference: 8928610 - Acta Neuropathol. 1996;91(4):343-50
– reference: 11010842 - J Infect Dis. 2000 Nov;182(5):1343-9
– reference: 12438606 - J Virol. 2002 Dec;76(24):12813-22
– reference: 11756157 - Blood. 2002 Jan 1;99(1):88-94
SSID ssj0031808
Score 2.2849119
Snippet Recently, human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ), encoded from a minus strand mRNA was discovered and was suggested to...
BACKGROUND: Recently, human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ), encoded from a minus strand mRNA was discovered and was...
Abstract Background Recently, human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ), encoded from a minus strand mRNA was discovered...
SourceID doaj
pubmedcentral
biomedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 19
SubjectTerms Aged
Basic-Leucine Zipper Transcription Factors - genetics
Basic-Leucine Zipper Transcription Factors - immunology
Case-Control Studies
Cell Line, Tumor
Cells, Cultured
Female
Gene expression
Gene Products, tax - genetics
Gene Products, tax - immunology
Genetic aspects
HTLV-I infections
Human T-lymphotropic virus 1 - genetics
Human T-lymphotropic virus 1 - immunology
Humans
Interferon-alpha - therapeutic use
Leucine
Leukemia-Lymphoma, Adult T-Cell - drug therapy
Leukemia-Lymphoma, Adult T-Cell - immunology
Leukemia-Lymphoma, Adult T-Cell - virology
Leukocytes, Mononuclear - immunology
Leukocytes, Mononuclear - virology
Male
Measurement
Messenger RNA
Middle Aged
Neopterin - cerebrospinal fluid
Paraparesis, Tropical Spastic - drug therapy
Paraparesis, Tropical Spastic - immunology
Paraparesis, Tropical Spastic - virology
Retroviridae Proteins
Severity of Illness Index
Spinal Cord Diseases - drug therapy
Spinal Cord Diseases - immunology
Spinal Cord Diseases - virology
Viral Load
Viral Proteins - genetics
Viral Proteins - immunology
Viremia
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9QwFA6yIPgi3h1d9TwIKlimt7SNb7PiUsUVwVlZfAm5lR2YaZed2cX5b_44z0nbdcIivvjYJm1uX875kpycw9jLJE-TvHE6MkgOKISZiYRBYchTJYyIlVXeffHRl6I-zj-d8JOdUF9kE9a7B-47btoYbePGxNwKnpfWKfoVt7rivFQ881f3UOeNi6leBiNQfSw6pNtYAVwADu4ak6qYXr2Lioj86wT33JeBevJe_K_L6h1lFRpS7mimwzvs9kApYdY35S674dp77GYfZHJ7n_362MLl4rID93Mwem2hawCJH9QHPwAB5Oi5nn_-HiVgKFrHkggo0BYt-C0HLBSWnbJvAfGIEFr5o3lYkWnP-RpUa2E46AFUtI7i4WHO8ZdqQICzsNqShRKSzi0ZKZ8RQABFGvmKBnJCTubw68UaXtezo-n829c3D9jx4Yf5-zoaYjZEmpdiE7kqtbpEzuW4QTKpLPIPbXOCRJlVmmN6Y_KUtr9KXSSuQlCkhVXIypLMZDx7yPbarnWPGcQ8NtwhwxTW5VpxwQ1PGt5UonSlisWEvQuGTp71_jkkecwOU3DyShp3SeMuC5ngx9E4ztIM3tApKMdS-lVRVVzL_-oq_1jO33IeEGyC2vgXiGo5oFr-C9VYHIFOkpTBahk1XJbAniF_XXKWIDPOid1P2H6QE6WDCZJfjLCVlEQmda3rLtaS7mdVqOom7FEP4j_tEimSlhS_LQN4B00KU9rFqXdNnhY8y4v4yf_og6fsVn90l-I83Wd7m_ML9wwZ4EY_95P9N1fmWZE
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1tb9MwELbQJiS-IMZrYcB9QAIkwvLmJEZCqENMBVGERIsmvliO7UClNBlNN63_jR_HnZN2CwWJj43PdWI_53tsn-8YexLEYRAXNvc0kgNKYaY9oXEy5KESWvjKKBe-ePwpGU3jD8f8-ML_qevA5q9LO8onNV2UL89_rt6gwr92Cp8lB0iqsRlc5nmJRxFAd9EqpZTNYBxvThQQui473Ua2C-C4Xf-Pm-9lz2C5uP7bs_cl89V3rbxkq45usOsdyYRhi4o9dsVWN9nVNu3k6hb79b6Cs9lZDfa8c4OtoC4AqSCMDr8BQsrS79Hk41cvAE35O0qipECbtuA2IbBRKGtlXgD2GYJq7g7rYU7OPosGVGWgO_oBNL2WMuSh5PovVYcJa2C-Ip8lpKErcls-IcgATnIUPRooLDk5yDezBp6NhuODyZfPz2-z6dG7yduR12Vx8HKeiqVns9DkKbIwyzXSS2WQkeQmJpCkUZZzLC90HNKGWJongc0QJmFiFPK0INIRj-6wnaqu7D0GPvc1t8g5hbFxrrjgmgcFLzKR2lT5YsBe9YZOnrQROyTF0O6XoDpLGndJ4y4TGWBlbz3OUnfx0SlNRyndOilLtuSfbuTX7fxL8pBg03sb96BefJfdBCELnRu_0D43gsepsYpUhps84zxVPKLmCHSSNAFfS6vu-gT2DEXwksMAuXJMfH_A9nuSOF_oXvHjNWwlFZGTXWXr00bSja0Mjd-A3W1BfPFdIkQaE2LdtAfv3if1S6rZDxesPEx4FCf-_f_urQfsWntiF6Iy7rOd5eLUPkTit8wfOY3-DZbjVRE
  priority: 102
  providerName: Scholars Portal
Title In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)
URI https://www.ncbi.nlm.nih.gov/pubmed/19228429
https://www.proquest.com/docview/67008911
http://dx.doi.org/10.1186/1742-4690-6-19
https://pubmed.ncbi.nlm.nih.gov/PMC2653460
https://doaj.org/article/fcbd0fc05d9547dea9c175db8557a539
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELdgExIviG8Ko9wDEiARLR92nPDWok0B0WmCDlV7sRzbEZXaZFq7if5v_HHc5WNbVvHES6XG5zjJ_Xz-2T7fMfY24GHAC5d7BskBpTAzXmrQGIpQpyb1tdV1-OLJUZyd8K8zMbte77i1gx8k8T5SZrwJTuK82KP4nrshxys0Lx-fdjYXgVnnnruSbcMzbte_da590RuO6qj927b5xuDUd5y8MRIdPmQPWgoJo0bnj9gdVz5m95qkkpsn7M-XEi7nlxW4362TawlVAUj0IBufAgLG0f9s-u2nF4Ch7BwLIpxAS7JQLzFgo7CotP0IiD-EzLLeioclufKcr0CXFtqNHcCB1VH-O5TsbqlbjTsLyw15JCHJ3JBT8hkBAtCEUWxooKDj5P6-mq_gfTaa7E9_HH94yk4OD6afM6_N0eDlQqZrzyWhzSVyLCcMkkdtkW_klhMEZJTkAssLw0Na7pJ5HLgEQRDGViMLCyITiegZ2ymr0r1g4AvfCIeMMrWO51qkwoigEEWSSie1nw7Yp57q1FkTj0NRhOx-CXZWRXpXpHcVqwAre52elWmjn1MSjoWqZ0FJvCX_7kq-a-dfkmOCTe9p6gsIYtV2f1WY3PqF8YVNBZfWaeoQwuaJEFKLiJoj0CmyKvhYRreHI_DLUHwuNQqQCXNi8wO215NEa2B6xW862CoqIhe60lUXK0XnsRIc2gbseQPi6_dKQyQpIdaVPXj3XqlfUs5_1aHIw1hEPPZf_o9qXrH7zRZdiP1zj-2szy_ca2R663zI7sqZHLLd8cHR8fdhvV6CvxOeDOvu_xeKGFTY
linkProvider BioMedCentral
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLamIQQviPsKg50HJEAiLDfnwluLGBm0ExIdmvZiObYDldpkSruJ_jd-HOc4yWioeOIx9XEc15-PP9vnwtgLL_S9sDC5o5AcUAoz5aQKlSH3ZapSV2ppwxdPTqLsNPx0xs922MfOF6Y2K9pK1_ZM-e2mC_rc6u3OXKyZ7Ul0iIwa28A9nhM5FP7zRsx5bB25RuedSkbc2tR017Jt9Mbt-n-5vc97q5UN6r-tujfWrr5d5cZCdXSX3WkZJgybLtxjO6a8z242OSfXD9iv4xKuZlcVmJ-tDWwJVQHIAyEbnQPiydBzNh1_czxQlLxjTnwU6MQW7AkENgrzSuo3gPBERC3sTT0syNKnXoIsNbT3PoDrrqH0eCjZvVK2gDAaFmsyWEIOuiab5QvCC6CGo9DRQDHJyTp-OVvCq2w4OZx-_fL6ITs9-jB9nzltCgcn53G6ckzi6zxGCma4Qm4pNdKRXIeEkDhIco7lhQp9Og2L88gzCWLEj7REkuYFKuDBI7ZbVqXZY-ByV3GDhDPVJswlT7niXsGLJI1NLN10wN71hk5cNOE6BAXQ7pcgkASNu6BxF5HwsLLTjbNQbXB0ytExF3aTlERb8i-v5bt2_iU5Itj0vsb-UNXfRYtmUahcu4VyuU55GGsjab5wnSeIZckDao5AJ0jp4Gcp2fpO4D9D4bvE0EOiHBLZH7D9niQqC9UrPuhgK6iILOxKU10uBblrJbjyDdjjBsR_-pX6yGF8rBv34N3rUr-knP2wkcr9iAdh5D75n6E5YLey6WQsxscnn5-y281tno9zdZ_trupL8wxJ4Sp_bif8b0doYHE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LbxMxELaqIhAXxJtAoXNAAiSW7Mv74JYA0RbaqoIUVb1YXtsLEclulKQV-W_8OGa8uyVLxIlbEo_jbPx5_Nkef8PYcy_0vbAwuaOQHFAKM-WkCp0h92WqUldqaeWLj46j7DT8eMbPdljW3oVZmBUtpRd2T_nN5hX0qfXb-EL96M91UQ_3JOojpcZGcJHnRA7pf16LOY8pl8Hn4XnrkxG4NjfdlW0j37hd_69779POdGVV_bd998bk1Q2s3JipRrfZrYZiwqDGxB22Y8q77HqddHJ9j_06KOFyclmB-dkEwZZQFYBEELLhOSCgDL3PxodfHQ8UZe-YEiEF2rIFuwWBjcK0kvo1ID4RUjN7VA8zCvVZLEGWGpqDH8CJ11B-PLRsv1I2iDAaZmuKWEISuqag5TkBBtDFkXY0kCg5hccvJ0t4mQ2O-uMvJ6_us9PRh_G7zGlyODg5j9OVYxJf5zFyMMMVkkupkY_kOiSIxEGScywvVOjTdlicR55JECR-pCWyNC9QAQ8esN2yKs0jBi53FTfIOFNtwlzylCvuFbxI0tjE0k177G2n68S81usQpKDdLUEkCep3Qf0uIuFhZaftZ6EadXRK0jEVdpWURFv2L67s23b-ZTkk2HR-jf2gWnwTjXsQhcq1WyiX65SHsTaSBgzXeYJYljyg5gh0grwODQHZXJ7Af4b0u8TAQ6YcEtvvsb2OJXoL1Sneb2ErqIhC7EpTXSwF3ddKcOrrsYc1iP88V-ojifGxbtyBd-eRuiXl5LuVKvcjHoSR-_h_umaf3Th5PxKHB8efnrCb9Wmej0N1j-2uFhfmKZLCVf7MjvffoCxgPA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+vivo+expression+of+the+HBZ+gene+of+HTLV-1+correlates+with+proviral+load%2C+inflammatory+markers+and+disease+severity+in+HTLV-1+associated+myelopathy%2Ftropical+spastic+paraparesis+%28HAM%2FTSP%29&rft.jtitle=Retrovirology&rft.au=Saito%2C+Mineki&rft.au=Matsuzaki%2C+Toshio&rft.au=Satou%2C+Yorifumi&rft.au=Yasunaga%2C+Jun-ichirou&rft.date=2009-02-19&rft.issn=1742-4690&rft.eissn=1742-4690&rft.volume=6&rft.issue=1&rft_id=info:doi/10.1186%2F1742-4690-6-19&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_1742_4690_6_19
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-4690&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-4690&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-4690&client=summon